214 related articles for article (PubMed ID: 22717543)
1. Elevation of fatty acid-binding protein 4 is predisposed by family history of hypertension and contributes to blood pressure elevation.
Ota H; Furuhashi M; Ishimura S; Koyama M; Okazaki Y; Mita T; Fuseya T; Yamashita T; Tanaka M; Yoshida H; Shimamoto K; Miura T
Am J Hypertens; 2012 Oct; 25(10):1124-30. PubMed ID: 22717543
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II receptor blockers decrease serum concentration of fatty acid-binding protein 4 in patients with hypertension.
Furuhashi M; Mita T; Moniwa N; Hoshina K; Ishimura S; Fuseya T; Watanabe Y; Yoshida H; Shimamoto K; Miura T
Hypertens Res; 2015 Apr; 38(4):252-9. PubMed ID: 25672659
[TBL] [Abstract][Full Text] [Related]
3. Association of insulin resistance and hyperinsulinemia with disturbed lipid metabolism in patients with essential hypertension.
Agata J; Miyazaki Y; Takada M; Murakami H; Masuda A; Miura T; Ura N; Shimamoto K
Hypertens Res; 1998 Mar; 21(1):57-62. PubMed ID: 9582109
[TBL] [Abstract][Full Text] [Related]
4. Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension.
Furuhashi M; Ura N; Higashiura K; Murakami H; Tanaka M; Moniwa N; Yoshida D; Shimamoto K
Hypertension; 2003 Jul; 42(1):76-81. PubMed ID: 12796280
[TBL] [Abstract][Full Text] [Related]
5. Role of adiponectin in insulin-resistant hypertension and atherosclerosis.
Murakami H; Ura N; Furuhashi M; Higashiura K; Miura T; Shimamoto K
Hypertens Res; 2003 Sep; 26(9):705-10. PubMed ID: 14620925
[TBL] [Abstract][Full Text] [Related]
6. Circulating resistin levels in essential hypertension.
Furuhashi M; Ura N; Higashiura K; Murakami H; Shimamoto K
Clin Endocrinol (Oxf); 2003 Oct; 59(4):507-10. PubMed ID: 14510915
[TBL] [Abstract][Full Text] [Related]
7. Serum fatty acid-binding protein 4 is a predictor of cardiovascular events in end-stage renal disease.
Furuhashi M; Ishimura S; Ota H; Hayashi M; Nishitani T; Tanaka M; Yoshida H; Shimamoto K; Hotamisligil GS; Miura T
PLoS One; 2011; 6(11):e27356. PubMed ID: 22102888
[TBL] [Abstract][Full Text] [Related]
8. Elevation of circulating fatty acid-binding protein 4 is independently associated with left ventricular diastolic dysfunction in a general population.
Fuseya T; Furuhashi M; Yuda S; Muranaka A; Kawamukai M; Mita T; Ishimura S; Watanabe Y; Hoshina K; Tanaka M; Ohno K; Akasaka H; Ohnishi H; Yoshida H; Saitoh S; Shimamoto K; Miura T
Cardiovasc Diabetol; 2014 Aug; 13():126. PubMed ID: 25142635
[TBL] [Abstract][Full Text] [Related]
9. Lipocalin-2, A-FABP and inflammatory markers in relation to flow-mediated vasodilatation in patients with essential hypertension.
Park CG; Choi KM
Clin Exp Hypertens; 2014; 36(7):478-83. PubMed ID: 24491219
[TBL] [Abstract][Full Text] [Related]
10. Circulating level of fatty acid-binding protein 4 is an independent predictor of metabolic dysfunction-associated fatty liver disease in middle-aged and elderly individuals.
Tanaka M; Takahashi S; Higashiura Y; Sakai A; Koyama M; Saitoh S; Shimamoto K; Ohnishi H; Furuhashi M
J Diabetes Investig; 2022 May; 13(5):878-888. PubMed ID: 34889064
[TBL] [Abstract][Full Text] [Related]
11. Possible Increase in Serum FABP4 Level Despite Adiposity Reduction by Canagliflozin, an SGLT2 Inhibitor.
Furuhashi M; Matsumoto M; Hiramitsu S; Omori A; Tanaka M; Moniwa N; Yoshida H; Ishii J; Miura T
PLoS One; 2016; 11(4):e0154482. PubMed ID: 27124282
[TBL] [Abstract][Full Text] [Related]
12. High plasma immunoreactive leptin level in essential hypertension.
Agata J; Masuda A; Takada M; Higashiura K; Murakami H; Miyazaki Y; Shimamoto K
Am J Hypertens; 1997 Oct; 10(10 Pt 1):1171-4. PubMed ID: 9370390
[TBL] [Abstract][Full Text] [Related]
13. Serum fatty acid-binding protein 4 (FABP4) concentration is associated with insulin resistance in peripheral tissues, A clinical study.
Nakamura R; Okura T; Fujioka Y; Sumi K; Matsuzawa K; Izawa S; Ueta E; Kato M; Taniguchi SI; Yamamoto K
PLoS One; 2017; 12(6):e0179737. PubMed ID: 28654680
[TBL] [Abstract][Full Text] [Related]
14. Adipose-Derived Fatty Acid-Binding Proteins Plasma Concentrations Are Increased in Breast Cancer Patients.
Guaita-Esteruelas S; Saavedra-García P; Bosquet A; Borràs J; Girona J; Amiliano K; Rodríguez-Balada M; Heras M; Masana L; Gumà J
Oncologist; 2017 Nov; 22(11):1309-1315. PubMed ID: 28701570
[TBL] [Abstract][Full Text] [Related]
15. Systolic blood pressure and fatty acid-binding protein 4 predict pregnancy-induced hypertension in overweight nulliparous women.
Tuuri AL; Jauhiainen MS; Tikkanen MJ; Kaaja RJ
Placenta; 2014 Oct; 35(10):797-801. PubMed ID: 25130095
[TBL] [Abstract][Full Text] [Related]
16. The role of serum adipocyte fatty acid-binding protein on the development of metabolic syndrome is independent of pro-inflammatory cytokines.
Park SE; Rhee EJ; Lee WY; Kim WJ; Yoo SH; Bae JC; Choi ES; Park CY; Oh KW; Park SW; Kim SW
Nutr Metab Cardiovasc Dis; 2012 Jun; 22(6):525-32. PubMed ID: 21186114
[TBL] [Abstract][Full Text] [Related]
17. Plasma leptin levels strongly correlate with plasma renin activity in patients with essential hypertension.
Uçkaya G; Ozata M; Sonmez A; Kinalp C; Eyileten T; Bingol N; Koc B; Kocabalkan F; Ozdemir IC
Horm Metab Res; 1999 Jul; 31(7):435-8. PubMed ID: 10450836
[TBL] [Abstract][Full Text] [Related]
18. Circulating Fatty Acid-Binding Protein 4 Concentration Predicts the Progression of Carotid Atherosclerosis in a General Population Without Medication.
Furuhashi M; Yuda S; Muranaka A; Kawamukai M; Matsumoto M; Tanaka M; Moniwa N; Ohnishi H; Saitoh S; Shimamoto K; Miura T
Circ J; 2018 Mar; 82(4):1121-1129. PubMed ID: 29445067
[TBL] [Abstract][Full Text] [Related]
19. Circulating Adipocyte Fatty Acid Binding Protein (FABP4) Levels Are Associated with Irisin in the Middle-Aged General Chinese Population.
Zhang S; Yang L; Chen P; Jin H; Xie X; Yang M; Gao T; Hu C; Yu X
PLoS One; 2016; 11(1):e0146605. PubMed ID: 26752184
[TBL] [Abstract][Full Text] [Related]
20. The association of serum adipocyte fatty acid-binding protein with coronary artery disease in Korean adults.
Rhee EJ; Lee WY; Park CY; Oh KW; Kim BJ; Sung KC; Kim BS
Eur J Endocrinol; 2009 Feb; 160(2):165-72. PubMed ID: 19001529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
